Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

NCT04856774 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-1701；BP102

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.